|
V.I. Simanenkov, N.V. Bakulina, Т.S. Fil, A.Kh. Khubieva
EVALUATION OF EFFICIENCY OF H. PYLORI ERADICATION IN CASE OF ADDITION OF CYTOPROTECTIVE PREPARATION REBAMIPIDE TO THE TREATMENT: RESULTS OF THE BASTION TRIAL
|
№s5-17 / 2017
|
|
V.V. Tsukanov, E.V. Kasparov, A.V. Vasyutin, Yu.L. Tonkikh, O.V. Peretyatko
MODERN ASPECTS OF MANAGEMENT OF PATIENTS WITH HELICOBACTER PYLORI-ASSOCIATED DISEASES: RECOMMENDATIONS OF THE EUROPEAN MAASTRICHT-V CONSENSUS
|
№13 / 2017
|
|
I.V. Mayev, D.N. Andreev, A.A. Samsonov, D.T. Dicheva, A.V. Zaborovsky, E.V. Partsvania-Vinogradova
ERADICATION OF HELICOBACTER PYLORI INFECTION AS A STRATEGY FOR THE PREVENTION OF STOMACH CANCER: STATEMENTS OF MAASTRICHT-V CONSENSUS (2015)
|
№2 / 2017
|
|
N.V. Zakharova (1), V.I. Simanenkov (1), I.G. Bakulin (1), O.A. Sablin (2), T.A. Ilchishina (2), D.V. Zakharov (3)
PREVALENCE OF HELICOBACTER PYLORI INFECTION IN GASTROENTEROLOGICAL PATIENTS IN SAINT PETERSBURG
|
№s5-16 / 2016
|
|
N.V. Zakharova, I.G. Bakulin, V.I. Simanenkov, A.A. Maslygina
REVIEW OF THE MAASTRICHT V/FLORENCE CONSENSUS RECOMMENDATIONS ON THE DIAGNOSIS AND TREATMENT OF HELICOBACTER PYLORI INFECTION
|
№s5-16 / 2016
|
|
N.V. Zaharova (1), V.I. Simanenkov (1), I.V. Savilova (1), A.V. Svarval (2)
HELICOBACTER PYLORI - ISOTOPIC DIAGNOSIS OF INFECTION AND TESTING OF RESISTANCE
|
№2 / 2016
|
|
A.A. Samsonov (1), D.N. Andreev (1), V.B. Grechushnikov (2), R.A. Aivazova (1)
RESISTANCE OF HELICOBACTERPYLORI TO THE COMPONENTS OF ERADICATION THERAPY AND WAYS FOR ITS OVERCOMING
|
№2 / 2015
|
|
D.N. Andreev, A.A. Samsonov
FUNCTIONAL DYSPEPSIA AND HELICOBACTERPYLORI INFECTION: HOW CLEAR IS RELATIONSHIP?
|
№2 / 2015
|
|
I.V. Mayev, A.A. Samsonov, N.N. Golubev
Treatment Of Helicobacter Pylori Infection
|
№2 / 2012
|
|
P.L. Shcherbakov, N.L. Belousova, M.Yu. Shcherbakova, V.S. Kashnikov
Use Of Suspension Of Nitrofurans In Complex Therapy Of Hp Infection
|
№15 / 2010
|
|
S.Yu. Konanychina, O.A. Serduk, I.I. Stepanova, M.L. Kastorina
Nifuratel-based Helicobacter Pylori Eradication Scheme In Children And Adults: Evaluation Of Efficacy With The Help Of Hp-antigen Method
|
№13 / 2009
|
|
I.V. Maev. A.A. Samsonov, N.N. Golubev
Clarithromycin As Inherent Component Of Anti-helicobacter Therapy
|
№6 / 2009
|
Русский
